Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 1,391 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Pill Clear all

Conditions: Crohn's Disease
Interventions: Placebo Comparator, Rifaximin; Drug
Lead sponsor: Scott Lee; Other
Eligibility: 18 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pain
Interventions: Ketamine, Placebo (for Ketamine); Drug
Lead sponsor: iX Biopharma Ltd.; Other
Eligibility: 18 Years to 38 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Brain Injuries, Brain Injuries, Traumatic, Brain Injury, Chronic
Interventions: Tolcapone 200 MG, Placebo; Drug · Other
Lead sponsor: Sheppard Pratt Health System; Other
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Towson, Maryland

Conditions: Bipolar Disorder, Major Depressive Disorder
Interventions: Pregnenolone, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Osteoarthritis (OA) of the Knee
Interventions: oral suzetrigine, oral Oxycodone; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 21 Years to 89 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Mild Cognitive Impairment
Interventions: curcumin + bioperine; Dietary Supplement
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 55 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Sleep Apnea, Obstructive
Interventions: Placebo pill, Sedative, Room air, Oxygen; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne
Interventions: Tretinoin or Adapalene, Isotretinoin; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 12 Years to 30 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Davis, California • Sacramento, California

Conditions: Sickle Cell Disease
Interventions: SMART app; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Neutrophils.Hypersegmented &#X7C; Bld-Ser-Plas, STEMI - ST Elevation Myocardial Infarction
Interventions: Colchicine Pill; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 19 Years to 110 Years
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Methamphetamine, Amphetamine Dependence, Pharmacogenetics, Methamphetamine Dependence, Substance Abuse
Interventions: Bupropion; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heart Failure
Interventions: Placebo, Spironolactone 25mg, Aldosterone; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Contraception
Interventions: Misoprostol, Placebo; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Dementia Syndromes
Interventions: Estrogen hormone therapy, Estrogen plus progesterone hormone therapy, Placebo; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 65 Years to 79 Years · Female only
Enrollment: 7,525 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1996 – 2008
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Parkinson's Disease, Freezing of Gait, Cognitive Ability, General
Interventions: Droxidopa, sugar pill; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Chicago, Illinois • West Bloomfield, Michigan

Conditions: Tobacco Use Cessation
Interventions: Varenicline, Nicotine Patch, Placebo Patch, Placebo Tablet, Questionnaires, Counseling Sessions, Lab Session, Saliva Test; Drug · Behavioral · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stress Disorder, Post Traumatic
Interventions: D-Cycloserine, Alprazolam, Virtual Reality Exposure Therapy, Placebo; Drug · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Psoriasis, Psoriatic Arthritis
Interventions: Apremilast, Etanercept, Placebo tablet, Placebo injection; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 31
States / cities: Phoenix, Arizona • Bakersfield, California • Irvine, California + 27 more

Conditions: Nicotine Dependence
Interventions: Transcranial Direct Current Stimulation, sham, Nicotine patch, Placebo patch, Varenicline Pill, Placebo pill, Motivational Interviewing; Device · Drug · Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Systemic Sclerosis, Scleroderma
Interventions: treprostinil diethanolamine, placebo; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 24
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 21 more

Conditions: Alcohol Dependence, Insomnia
Interventions: Placebo dispensed to subject., Gabapentin dispensed to subject.; Drug
Lead sponsor: Dr. Kirk Brower; Other
Eligibility: 18 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Delirium, Cognition Disorders
Interventions: Ziprasidone, Haloperidol, Placebo; Drug · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 5
States / cities: Iowa City, Iowa • Chapel Hill, North Carolina • Greensboro, North Carolina + 1 more

Conditions: Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8
Interventions: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration; Procedure · Drug · Dietary Supplement + 1 more
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cerebrovascular Accident, Hypertension
Interventions: aspirin, clopidogrel, Target of Blood Pressure, placebo; Drug · Other
Lead sponsor: University of British Columbia; Other
Eligibility: 30 Years and older
Enrollment: 3,020 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 39
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 32 more

Search by objective public record fields.

Induction of Clinical Response Using Rifaximin in Crohn's Disease

Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction

A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury

Study Using Pregnenolone to Treat Bipolar Depression

Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty

Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine

Combination Therapy to Treat Sleep Apnea

The Lipid Profile of the Skin Surface in Acne

SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge

CLEAR SYNERGY Neutrophil Substudy

Study of Medical Treatment for Methamphetamine Addiction

Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing

Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

The Women's Health Initiative Memory Study (The WHIMS Study)

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Nicotine Withdrawal Symptoms and Smoking Relapse

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence

The MIND Study: Modifying the INcidence of Delirium

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

Secondary Prevention of Small Subcortical Strokes Trial